CARMA1 Controls Th2 Cell-Specific Cytokine Expression through Regulating JunB and GATA3 Transcription Factors

被引:31
作者
Blonska, Marzenna [1 ]
Joo, Donghyun [1 ,2 ]
Zweidler-McKay, Patrick A. [3 ]
Zhao, Qingyu [1 ]
Lin, Xin [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
[2] Univ Texas Houston, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; KINASE-C-THETA; ALLERGIC AIRWAY INFLAMMATION; LINEAGE COMMITMENT; MURINE MODEL; ACTIVATION; RECEPTOR; PHOSPHORYLATION; DIFFERENTIATION; RESPONSES;
D O I
10.4049/jimmunol.1102943
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The scaffold protein CARMA1 is required for the TCR-induced lymphocyte activation. In this study, we show that CARMA1 also plays an essential role in T cell differentiation. We have found that the adoptive transfer of bone marrow cells expressing constitutively active CARMA1 results in lung inflammation, eosinophilia, and elevated levels of IL-4, IL-5, and IL-10 in recipient mice. In contrast, CARMA1-deficient T cells are defective in TCR-induced expression of Th2 cytokines, suggesting that CARMA1 preferentially directs Th2 differentiation. The impaired cytokine production is due to reduced expression of JunB and GATA3 transcription factors. CARMA1 deficiency affects JunB stability resulting in its enhanced ubiquitination and degradation. In contrast, TCR-dependent induction of GATA3 is suppressed at the transcriptional level. We also found that supplementation with IL-4 partially restored GATA3 expression in CARMA1-deficient CD4(+) splenocytes and subsequently production of GATA3-dependent cytokines IL-5 and IL-13. Therefore, our work provides the mechanism by which CARMA1 regulates Th2 cell differentiation. The Journal of Immunology, 2012, 188: 3160-3168.
引用
收藏
页码:3160 / 3168
页数:9
相关论文
共 43 条
[1]   CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-κB [J].
Bertin, J ;
Wang, L ;
Guo, Y ;
Jacobson, MD ;
Poyet, JL ;
Srinivasula, SM ;
Merriam, S ;
DiStefano, PS ;
Alnemri, ES .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) :11877-11882
[2]   The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway [J].
Blonska, Marzenna ;
Pappu, Bhanu P. ;
Matsumoto, Reiko ;
Li, Hongxiu ;
Su, Bing ;
Wang, Demin ;
Lin, Xin .
IMMUNITY, 2007, 26 (01) :55-66
[3]   NF-κB signaling pathways regulated by CARMA family of scaffold proteins [J].
Blonska, Marzenna ;
Lin, Xin .
CELL RESEARCH, 2011, 21 (01) :55-70
[4]   CARMA1-mediated NF-κB and JNK activation in lymphocytes [J].
Blonska, Marzenna ;
Lin, Xin .
IMMUNOLOGICAL REVIEWS, 2009, 228 :199-211
[5]   A critical role for NF-κB in Gata3 expression and TH2 differentiation in allergic airway inflammation [J].
Das, J ;
Chen, CH ;
Yang, LY ;
Cohn, L ;
Ray, P ;
Ray, A .
NATURE IMMUNOLOGY, 2001, 2 (01) :45-50
[6]   AP-1: A double-edged sword in tumorigenesis [J].
Eferl, R ;
Wagner, EF .
NATURE REVIEWS CANCER, 2003, 3 (11) :859-868
[7]   Requirement for CARMA1 in antigen receptor-induced NF-κB activation and lymphocyte proliferation [J].
Egawa, T ;
Albrecht, B ;
Favier, B ;
Sunshine, MJ ;
Mirchandani, K ;
O'Brien, W ;
Thome, M ;
Littman, DR .
CURRENT BIOLOGY, 2003, 13 (14) :1252-1258
[8]   c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors [J].
Fuchs, SY ;
Xie, B ;
Adler, V ;
Fried, VA ;
Davis, RJ ;
Ronai, Z .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) :32163-32168
[9]  
Fuchs SY, 1996, ONCOGENE, V13, P1531
[10]   Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase itch [J].
Gao, M ;
Labuda, T ;
Xia, Y ;
Gallagher, E ;
Fang, D ;
Liu, YC ;
Karin, M .
SCIENCE, 2004, 306 (5694) :271-275